Search

everythinglearnresearchcommunity

for

Search:↓

Tapinarof cream at 1% concentration is effective and better tolerated for treating atopic dermatitis than the 2% concentration.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

[6]-Gingerdiol 3-monoacetate shows promise for treating T. whipplei infections.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Topical rapamycin may effectively treat fibrous papules on the face.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Some dermatologists in Saudi Arabia prescribe Tofacitinib for hair loss, but many don't due to its unavailability and safety concerns.

Tislelizumab can cause cutaneous lupus erythematosus.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

Early treatment with JAK inhibitors leads to better hair regrowth in acute alopecia areata.

Bedaquiline, Telmisartan, Diosmin, Azelastine, and Adapalene may be effective treatments for onchocerciasis.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

Tofacitinib is effective and safe for treating alopecia areata.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

The registry showed that tofacitinib is promising for treating hair loss in children with alopecia areata, but more research is needed.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Oral JAK inhibitors show promise for treating alopecia areata but have challenges like relapse and side effects.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Upadacitinib effectively treats psoriasis and lichen planus together.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

JAK inhibitors like tofacitinib can effectively treat severe alopecia areata.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Tofacitinib may cause nerve damage in the brain, so monitor for neurological symptoms.

Janus kinase inhibitors are effective and generally safe for treating hair loss in adults with alopecia areata.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.